Latest Blogs

Guest Commentary
Sep 26, 2023
Changing The Narrative: 10 Recommendations for Caring for Young Adults With Lung Cancer
Dr. Narjust Florez, Dr. Fatima Wilder, Lauren Kiel, and Rebekah Kaufman underscore the need to comprehensively understand and address the unmet needs of young patients with lung cancer.
Guest Commentary
Aug 25, 2023
Ensuring Evidence-Based Medicine Is Reflected in Coding and Reimbursement: An Update From ASCO’s Advisor to the AMA CPT Editorial Panel
Dr. Joseph Merchant introduces the CPT process and recognizes ASCO colleagues who have represented the interests of members on this issue.
Guest Commentary
Aug 23, 2023
What to Expect After Submitting Your Fellowship Application: Tips for Hematology-Oncology Fellowship Application From Current Fellows
HemOncFellows Network organized an online discussion to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship application.
Guest Commentary
Aug 17, 2023
Advanced Practice Providers (APPs) Are Essential to Continuity of Cancer Care, Especially in Rural Communities
"Oncologists and APPs working together have the opportunity to increase practice volume, improve access to care, and ensure continuity for the patient," said Whitney Pritham.
Subscribe to this column

Peter Paul Yu, MD, FASCO, FACP

Peter Paul Yu, MD, FACP, FASCO, is the physician-in-chief at Hartford HealthCare Cancer Institute. He is a past president of ASCO, past chair of the Breakthrough Co-Host Committee, and currently serves on the CancerLinQ Board of Governors, as an associate editor of JCO Clinical Cancer Informatics, and on the JCO Oncology Practice editorial board. Follow Dr. Yu on Twitter @YupOnc.

Disclosure.

Apr 16, 2012
Silicon Valley
It seems that every nephew or niece of mine who has an engineering degree is busy creating the next killer app for a mobile device. Usually it starts with way cool technology, but comes up short in figuring out why enough users would want it or what a sustainable business model might be. On the...
3 Comments
Mar 11, 2012
Is Health Information Technology a Driving Force for Change or Merely an Enabler of Change?
In health care, we often find ourselves reacting to events rather than dictating them. Being cast in this undesirable position is often unavoidable when dealing with regulators and federal policy. However, the ability to foresee the need for change and thereby influence the direction of change is a...
Nov 20, 2011
FDA Bevacizumab Decision
This week the FDA decided to withdraw bevacizumab's indication for treatment of metastatic breast cancer. The earlier indication had been approved under FDA's accelerated approval process wherein final approval was conditional on the generation of confirmatory evidence based on clinical trials.
Nov 10, 2011
IOM Envisioning a Transformed Clinical Trials Enterprise in the United States
This week the Institute of Medicine held a workshop on “Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020.” During the 2-day meeting a variety of...
Nov 06, 2011
ASCO HIT/EHR Symposium Day 2
Let me start by mentioning 2 things I missed earlier about Day 1 of the ASCO HIT/EHRs Symposium.  In the session on Usability, Karen Bell, Chair of CCHIT, mentioned 3 areas where EHRs may impact malpractice risk; Communications, Documentation and Medical Errors. Each of these has the potential to...
1 Comments
Nov 06, 2011
Generic Drug Shortage
The November 3rd edition of the NEJM features a Perspective article on drug shortages by Mandy Gatesman and Thomas J Smith (NEJM 365:18 page 163) that address many of the causative issues that underlie this growing national problem.  

Pages